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Introduction
Antiviral treatment is associated with reduced mortality,
length of stay and improved clinical outcomes among
patients hospitalized with influenza.
Objectives
We wished to assess trends in use of antiviral treatment
of adults hospitalized with influenza before , during and
after the 2009 influenza pandemic
Methods
CNISP has carried out prospective surveillance for
laboratory confirmed influenza in hospitalized adults
since 2006. These data were reviewed to assess antiviral
use.
Results
A higher proportion of adults hospitalized with labora-
tory-confirmed influenza received antiviral treatment
during the 2009 influenza pandemic (997/1,113; 89.6%)
compared with the 2010-2011 (873/1,092; 80.0%,
p<0.001) and 2011-12 (391/600; 65.2%, p<0.001) influ-
enza seasons. The decrease in antiviral us . e between
the 2009 pandemic season and the 2010-11 season was
statistically significant in all age groups except for inpa-
tients ≥65 years. A decrease in antiviral use among inpa-
tients ≥65 years was not observed until the 2011-2012
season. A median of 3 days between symptom onset and
antiviral treatment was reported for all three influenza
seasons. Among high-risk groups, adults with underlying
medical conditions were significantly more likely to
receive antiviral treatment during the pandemic than
during the post-pandemic seasons (89.7% vs. 75.7%,
p<0.001). A higher proportion of adults admitted to the
ICU during the 2009 pandemic (94.2%) received anti-
viral treatment compared with the 2010-11 and 2011-12
seasons (84.6%, p<0.001). There was no difference in
antiviral treatment among inpatients who died within 30
days of admission during the pandemic (84.3%) than
during the post-pandemic seasons (78.9%, p=0.370).
Conclusion
Antiviral treatment of adults hospitalized with labora-
tory-confirmed influenza significantly fell in the two sea-
sons following the 2009 influenza pandemic. In order to
guide strategies aimed at minimizing the impact of influ-
enza among hospitalized adults, reasons for the decline
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